BioSpace News Archive

Biotech Bay

Boehringer Ingelheim receives SBTi validation for CO2 reduction targets

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, said on Thursday it is well on track to achieve its 2030 emission reduction targets, and that it had received approval of those targets from the Science Based Targets initiative.

September 14, 2023

·

3 min read

Medivir to present at the Pareto Securities Healthcare Conference - September 14, 2023

Medivir AB announces that the company will present at the Pareto Securities Healthcare Conference.

September 14, 2023

·

1 min read

Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL

Dizal today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for golidocitinib for the treatment of relapsed or refractory peripheral T-cell lymphoma (r/r PTCL).

September 14, 2023

·

4 min read

Business

First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi

First Wave BioPharma, Inc., announced an agreement with Sanofi to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop for gastrointestinal indications.

September 14, 2023

·

5 min read

Drug Development

Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics

Generate:Biomedicines, a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform, announced that it has raised $273 million in Series C financing.

September 14, 2023

·

5 min read

BioMidwest

AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

AlveoGene announces its launch in conjunction with seed funding raised from Oxford Science Enterprises, Harrington Discovery Institute at University Hospitals, and with participation from Old College Capital, the University of Edinburgh’s venture investment fund.

September 14, 2023

·

9 min read

Genetown

PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device

PathMaker Neurosystems Inc. announced the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis.

September 14, 2023

·

3 min read

Fujitsu and Baptist Health South Florida transform operating room scheduling with newly launched solution to boost utilization rates and the financial health of the surgical discipline

Fujitsu announced the launch of an innovative solution to its Uvance Healthy Living portfolio to transform surgical capacity utilization with a new approach in the market by targeting the root cause of surgical block time inefficiencies.

September 14, 2023

·

1 min read

Genetown

Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD

Bionomics Limited announced an update on the company’s α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator collaboration with MSD.

September 14, 2023

·

5 min read

BioForest

NanoString to Host Virtual Spatial Genomics Summit September 19, 2023

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual Spatial Genomics Summit, September 19th.

September 14, 2023

·

3 min read